COMPANY
Board of Directors
Nobles Medical Technologies™ II, Inc. is a Delaware Corporation that was formed in December, 2009. The Company’s headquarters is located at 17072 Newhope Street, Fountain Valley, California 92708. Under the direction of Prof. Anthony Nobles, HeartStitch® is commercializing its first interventional device—the NobleStitch™ EL—while simultaneously developing other surgical technologies. The Board of Directors within the company are as follows:
Board of Directors
Nobles Medical Technologies™ II, Inc. is a Delaware Corporation that was formed in December, 2009. The Company’s headquarters is located at 17072 Newhope Street, Fountain Valley, California 92708. Under the direction of Prof. Anthony Nobles, HeartStitch® is commercializing its first interventional device—the NobleStitch™ EL—while simultaneously developing other surgical technologies. The Board of Directors within the company are as follows:
Prof. Anthony Nobles, Chairman of Board of Directors & CEO
Prof. Anthony Nobles is currently the Chairman and CEO of NMT2, and has served as an officer and director of NMT2 since its inception in 2009. Prof. Nobles has founded more than 28 companies in the fields of Electronics, Medical Devices and Automotive engineering. He is also currently a Professor of Biomedical Engineering at the Westsachsische Hochschule in Zwickau, Germany. Prof. Nobles has personally invented and developed numerous medical devices, as well as other technologies, and has been awarded patents for many of his inventions in various areas including neurosurgery, cardiac surgery, cardiology, ObGyn and vascular surgery. Prof. Nobles has been a contributing author for publications on Endovascular Surgery, Angioscopy, Surgical Technology, Neurosurgery, Cardiology, Neuro Endoscopy and Laparoscopic Surgery. He has lectured and presented at the American College of Surgeons, the American Association of Neurological Surgeons, the Society of Vascular Surgery, the University of California at Los Angeles, University of Southern California, Chapman University, Rose-Hulman Institute of Technology, Harvard Medical School, and the International Society of Neurology and Neurological Surgeons, the Paris Congress of Cardiology, Congenital Structural Interventions (CSI) Structural Heart Meeting. Prof. Nobles is 53 years of age. |
Ben Brosch, President and Member of Board of Directors
Mr. Brosch is the former President of NMT2 and had served as the President from 2012 – 2016, and has served as a Director since 2012. Mr. Brosch has over 35 years of experience in engineering, manufacturing and management, with more than 18 years of experience in the Med-Device space. Mr. Brosch is a named inventor on several patents for innovative medical devices in the fields of general surgery, vascular surgery, neurosurgery, ObGyn, cardiac surgery and cardiology. Mr. Brosch has cofounded and served as an executive of several Med-Device companies. Mr. Brosch is 66 years of age. |
Richard Babcock, Member of the Board and Chief Counsel
Mr. Babcock has served as NMT2’s outside corporate counsel since its inception in 2009, and has served as a member of the NMT2 Board since 2010. Mr. Babcock founded Babcock & Associates in 2005, and has served as the managing member since its inception. Mr. Babcock is a leading corporate advisor, and has more than 27 years of experience providing advice to emerging growth and middle market companies in connection with mergers and acquisitions, venture capital and private equity financings, as well as initial public offerings and follow-on offerings. His legal practice also includes providing advice to companies and their boards of directors on a broad range of general corporate and governance matters. Mr. Babcock’s clients have ranged from privately-held entrepreneur grown companies, to large, well-established public companies. He serves as general counsel to many of his clients and their management and boards of directors, helping to shape and execute their business strategies and advising them on day-to-day legal and other strategic issues. In his earlier practice, Mr. Babcock was a partner at the international law firms of McDermott, Will & Emery, Morrison & Foerster, and Sheppard Mullin. Mr. Babcock is 54 years of age. |
Antoine Felicelli, Member of the Board of Directors
Mr. Felicelli is currently serving as a Founding Partner of Bond Central LTD that acts as an arranger in securitization projects, and has served in such capacity since its inception in April 2017. Form 2012 until April 2017, Mr. Felicelli served as the CFO & COO and Board Member of Union Capital Group SA, an independent financial institution specializing in the trading and brokerage of structured products and cash equity. Prior to 2012, Mr. Felicelli served as the Managing Director of Union Investment Real Estate France, the French subsidiary of the Hamburg-based real estate asset manager and was responsible for the management of a EUR 3 billion French portfolio. Mr. Felicelli was appointed to the Board in August 2015, to fill a vacancy on the Board. He earned a bachelor’s degree in Business Administration from ESSEC Business School. Mr. Felicelli is 35 years of age. |